COMPARE · Data as of August 21, 2026
CVSA vs EDU
Verdict: Side-by-side breakdown using the Bull Rankings model. CVSA scored 79.6, EDU scored 86.0 — EDU leads.
Compare another set
Different reporting periods. CVSA's fundamentals are as of June 2026, but EDU's are as of May 2025 — a 13-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
CVSA
Covista Inc.
79.6
$128.04 · $4.4B
fundamentals as of
Score gap
6.4
EDU leads
EDU
New Oriental Education & Techno
86
$54.91
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestCVSA17.1x
- Fastest growthEDU+13.6%
- Strongest balance sheetEDU0.20
- Highest qualityCVSA80 / 100
- Largest discount to fair valueCVSA-55%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
Fundamentals, head-to-head
CVSA
EDU
$393mC
FCF
$655mC+
+9.3%B
Rev
+13.6%B+
0.63B+
D/E
0.20A-
17.1xB+
P/E
18.3xB+
0.97B+
PEG
1.03B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
CVSA
EDU
55% below
Price vs fair valuelower is cheaper
—
~-11%/yr
Growth the price implies10-yr FCF · lower = less priced in
—
+102%
1-yr DCF upside
—
+124%
5-yr DCF upside
—
+160%
10-yr DCF upside
—
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
CVSA
Why this score
- Buying back stock
EDU
No notable signals flagged.
The companies
CVSACovista Inc.
Why now
Education & Training Services · market cap $4.4b. 18% off the 52-week high of $156.26. PEG 0.97 — paying under fair value for the growth rate. 4 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $159.50 (implying +25% upside).
Moat
Net margin 13% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 17% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 156% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
EDUNew Oriental Education & Techno
Why now
Education & Training Services · market cap n/a. 15% off the 52-week high of $64.97. Revenue growing +14%, comfortably above the S&P median. 21 sell-side analysts rate this a Buy with a mean 1-yr target of $73.30 (implying +33% upside).
Moat
ROE 10% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 176% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Verdict — model-derived comparison
The model favors CVSA with an 81.4 score, primarily due to its superior Quality pillar of 80 versus EDU's 70. However, a contrarian might prefer EDU for its stronger revenue growth of +13.6% (B+) and significantly lower debt-to-equity ratio of 0.20 (A-). Both stocks are in the same sector, with comparable scoring scales.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.